Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.23
-0.36 (-3.75%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Immatics Market Cap
Immatics has a market cap or net worth of $1.26 billion as of July 20, 2026. Its market cap has increased by 72.97% in one year.
Market Cap
1.26B
Enterprise Value
755.91M
1-Year Change
72.97%
Ranking
Category
Stock Price
$9.23
ChartMarket Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.26B, an increase of 631.30%. That is a compound annual growth rate of 29.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.26B | -10.38% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.38B |
| Aktis Oncology | 1.36B |
| Novavax | 1.31B |
| Ardelyx | 1.27B |
| First Tracks Biotherapeutics | 1.27B |
| Inhibrx Biosciences | 1.26B |
| Avalyn Pharma | 1.25B |
| MannKind | 1.24B |